Operation of stirred tank reactors (STRs) and fixed-bed reactors (FBRs) with free and immobilized Phanerochaete chrysosporium for the continuous removal of pharmaceutical compounds

Biochemical Engineering Journal

Volumn 66, Issue , 2012, Pages 38-45

  Rodarte Morales, A I ^a   Feijoo, G ^a   Moreira, M T ^a   Lema, J M ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Degradation; Fixed bed reactor (FBR); Pharmaceutical compounds; Stirred tank reactor (STR); White rot fungus (WRF)

Indexed keywords

AERATION SYSTEM; ANTI-INFLAMMATORIES; CARBAMAZEPINE; DEGRADATION PRODUCTS; DICLOFENAC; FIXED-BED REACTORS; FUNGAL PELLETS; NAPROXENS; PARENT COMPOUNDS; PHANEROCHAETE CHRYSOSPORIUM; PHARMACEUTICAL COMPOUNDS; REMOVAL EFFICIENCIES; RESIDUAL CONCENTRATIONS; STABLE OPERATION; STIRRED TANK REACTORS; TARGET COMPOUND; WHITE ROT FUNGI;

ADSORPTION; AMIDES; DEGRADATION; PELLETIZING; TANKS (CONTAINERS);

CHEMICAL REACTORS;

1 HYDROXY IBUPROFEN; 4 HYDROXY DICLOFENAC; 6 O DESMETHYL NAPROXEN; CARBAMAZEPINE; DIAZEPAM; DICLOFENAC; DRUG METABOLITE; IBUPROFEN; MANGANESE OXIDE; NAPROXEN; UNCLASSIFIED DRUG;

ADSORPTION; AERATION; ARTICLE; BIOMASS; DERIVATIZATION; DRUG DEGRADATION; DRUG ELIMINATION; FERMENTATION; FIXED BED REACTOR; FUNGUS GROWTH; GLUCOSE INTAKE; MYCELIUM; OXYGEN SUPPLY; PHANEROCHAETE; PRIORITY JOURNAL; STIRRED REACTOR;

FUNGI; PHANEROCHAETE CHRYSOSPORIUM;

EID: 84861217996     PISSN: 1369703X     EISSN: 1873295X     Source Type: Journal    
DOI: 10.1016/j.bej.2012.04.011     Document Type: Article

References (32)

1. Kummerer K. Sustainable from the very beginning: rational design of molecules by life cycle engineering as an important approach for green pharmacy and chemistry. Green Chem. 2007, 9:899-907.
2. Jjemba P.K. Excretion and ecotoxicity of pharmaceuticals and personal care products in the environment. Ecotoxicol. Environ. Saf. 2006, 63:113-130.
3. Fent K., Weston A.A., Caminada D. Review: ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
4. Ikehata K., Naghashkar N., El-Din M.G. Degradation of aqueous pharmaceuticals by ozonation and advanced oxidation processes: a review. Ozone: Sci. Eng. 2006, 28(6):353-414.
5. Daughton C.G., Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ. Health Perspect. 1999, 107(6):907-938.
6. Ternes T.A., Giger W., Joss A. Introduction. Human Pharmaceuticals, Hormones and Fragrances: The Challenge of Micropollutants in Urban Water Management 2006, 1-13. IWA Publishing, London, Chapter 1. T.A. Ternes, A. Joss (Eds.).
7. Field J.A., de Jong E., Feijoo G., de Bont J.A.M. Biodegradation of polycyclic aromatic hydrocarbons by new isolates of white rot fungi. Appl. Environ. Microbiol. 1992, 58(7):2219-2226.
8. Wesenberg D., Kyriakides I., Agathos S.N. White-rot fungi and their enzymes for the treatment of industrial dye effluents. Biotechnol. Adv. 2003, 22:161-187.
9. Marco-Urrea E., Pérez-Trujillo M., Cruz-Morató C., Caminal G., Vicent T. Degradation of the drug sodium diclofenac by Trametes versicolor pellets and identification of some intermediates by NMR. J. Hazard. Mater. 2010, 176:836-842.
10. Lloret L., Eibes G., Lú-Chau T., Moreira M.T., Feijoo G., Lema J.M. Laccase-catalyzed degradation of anti-inflammatories and estrogens. Biochem. Eng. J. 2010, 51:124-131.
11. Zhang Y., Geiβen S.U. In vitro degradation of carbamazepine and diclofenac by crude lignin peroxidase. J. Hazard. Mater. 2010, 176:1089-1192.
12. Eibes G., Debernardi G., Feijoo G., Moreira M.T., Lema J.M. Oxidation of pharmaceutically active compounds by a ligninolytic fungal peroxidase. Biodegradation 2011, 22:539-550.
13. Hata T., Shintate H., Kawai S., Okamura H., Nishida T. Removal of carbamazepine by repeated treatment with laccase in the presence of 1-hydroxybenzotriazole. J. Hazard. Mater. 2010, 181:1175-1178.
14. Marco-Urrea E., Pérez-Trujillo M., Vicent T., Caminal G. Ability of white-rot fungi to remove selected pharmaceuticals and identification of degradation products of ibuprofen by Trametes versicolor. Chemosphere 2009, 74:765-772.
15. Rogalski J., Szczodrak J., Janusz G. Manganese peroxidase production in submerged cultures by free and immobilized mycelia of Nematoloma frowardii. Bioresour. Technol. 2006, 97:469-476.
16. Moreira M.T., Feijoo G., Lema J.M. Manganese peroxidase production by Bjerkandera sp. BOS55: regulation of enzymatic production. Bioprocess. Eng. 2000, 23:657-661.
17. Moreira M.T., Feijoo G., Palma C., Lema J.M. Continuous production of manganese peroxidase by Phanerochaete chrysosporium immobilized on polyurethane foam in a pulsed packed-bed bioreactor. Biotechnol. Bioeng. 1997, 56(2):130-137.
18. Ehlers G.A., Rose P.D. Immobilized white-rot fungal biodegradation of phenol and chlorinated phenol in trickling packed-bed bioreactors by employing sequencing batch operation. Bioresour. Technol. 2005, 96:1264-1275.
19. Sedighi M., Karimi A., Vahabzadeh F. Involvement of ligninolytic enzymes of Phanerochaete chrysosporium in treating the textile effluent containing Astrazon Red FBL in a packed bed bioreactor. J. Hazard. Mater. 2009, 169:88-93.
20. Moreira M.T., Palma C., Feijoo G., Lema J.M. Strategies for the continuous production of ligninolytic enzymes in fixed and fluidised bed bioreactors. J. Biotechnol. 1998, 66:27-39.
21. Tien M., Kirk T.K. Lignin peroxidase of Phanerochaete chrysosporium. Methods in Enzymology-Biomass, Part b, Lignin, Pectin, and Chitin 1988, vol. 161:238-249. Academic Press Inc., San Diego, CA, USA.
22. Moreira M.T., Sanromán A., Feijoo G., Lema J.M. Control of pellet morphology of filamentous fungi in fluidized bed bioreactors by means of a pulsing flow. Application to Aspergillus niger and Phanerochaete chrysosporium. Enzyme Microb. Technol. 1996, 19:261-266.
23. Rodríguez I., Quintana J.B., Carpinteiro J., Carro A.M., Lorenzo R.A., Cela R. Determination of acidic drugs in sewage by gas chromatography-mass spectrometry as tert.-butylmethylsilyl derivatives. J. Chromatogr. 2003, 985:265-274.
24. Miller G.L. Use of dinitrosalicylic acid reagent for determination of reducing sugar. Anal. Chem. 1959, 31(3):426-428.
25. Stülten D., Zülke S., Lamshöft M., Spiteller M. Occurrence of diclofenac and selected metabolites in sewage effluents. Sci. Total Environ. 2008, 405:310-316.
26. Weigel S., Berger U., Jensen E., Kallenborn R., Thoresen H., Hühnerfuss H. Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromsø/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 2004, 56:583-592.
27. Ziylan A., Ince N.H., Review The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: treatability by conventional and non-conventional processes. J. Hazard. Mater. 2011, 187:24-36.
28. Joss A., Zabczynski S., Göbel A., Hoffmann B., Löffer D., McArdell C.S., Ternes T.A., Thomsen A., Siegrist H. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res. 2006, 40:1686-1696.
29. Huber M., Gobel A., Joss A., Hermann N., Löffler D., McArdell C.S., Ried A., Siegrist H., Ternes T.A., Von Gunten U. Oxidation of pharmaceuticals during ozonation of municipal wastewater effluents: a pilot study. Environ. Sci. Technol. 2005, 39:4290-4299.
30. Zhang Y., Geißen S.U., Gal C. Carbamazepine and diclofenac: removal in wastewater treatment plants and occurrence in water bodies. Chemosphere 2008, 73:1151-1161.
31. Calisto V., Esteves V.I. Psychiatric pharmaceuticals in the environment. Chemosphere 2009, 10:1257-1274.
32. Suárez S., Carballa M., Omil F., Lema J.M. How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters. Rev. Environ. Sci. Biotechnol. 2008, 7:125-138.